drugset / Trial / NCT05747430
SteRilizing Eye SoLution to ImprovE Patient ComFort (RELIEF)
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a randomized, double-masked study to evaluate the tolerability and safety of IRX-101 versus 5% povidone-iodine (PI) in subjects receiving intravitreal anti-VEGF injections. The study will be conducted in up to 15 centers in the United States (US).
Timeline
- Start
- 2023-02-22
- Primary completion
- 2025-03-06
- Completion
- 2026-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IRX-101 | Unknown | — | — |
| Comparator | Providone-Iodine | Unknown | 5 % | — |